Trials / Unknown
UnknownNCT00192803
Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs
ACE/ACE2 Ratio in Diabetic Patients Treated With Antihypertensive Drugs
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This feasibility study is designed to examine modulation of the relative activities of ACE and ACE2 in diabetic patients following treatment with the angiotensin type 1 receptor (AT1R) antagonist, Candesartan. This study will provide a closer insight to the possible involvement of the renin-angiotensin system (RAS)-related enzymatic components in development or attenuation of vascular pathogenesis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | candesartan |
Timeline
- First posted
- 2005-09-19
- Last updated
- 2006-02-23
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00192803. Inclusion in this directory is not an endorsement.